# Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID

> **NCT05696106** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 750000 (estimated)

## Conditions studied

- Inflammatory Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05696106
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-02
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-01-15
- **Target enrollment:** 750000 (ESTIMATED)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05696106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05696106, "Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05696106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*